You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors
|
---|---|
Published in |
Clinical Sarcoma Research, August 2014
|
DOI | 10.1186/2045-3329-4-9 |
Pubmed ID | |
Authors |
Maria A Pantaleo, Annalisa Astolfi, Milena Urbini, Fabio Fuligni, Maristella Saponara, Margherita Nannini, Cristian Lolli, Valentina Indio, Donatella Santini, Giorgio Ercolani, Giovanni Brandi, Antonio D Pinna, Guido Biasco |
Abstract |
Intragenic deletions of the dystrophin-encoding and muscular dystrophy-associated DMD gene have been recently described in gastrointestinal stromal tumor (GIST), rhabdomyosarcoma (RMS) and leiomyosarcoma (LMS). We evaluated the copy numbers and gene expression levels of DMD in our series of GIST patients who were already studied with wide genome assays, to investigate more fully a correlation between dystrophin status and disease annotations. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 33% |
Canada | 1 | 33% |
United States | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 25 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 40% |
Researcher | 5 | 20% |
Student > Bachelor | 3 | 12% |
Lecturer > Senior Lecturer | 1 | 4% |
Librarian | 1 | 4% |
Other | 2 | 8% |
Unknown | 3 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 7 | 28% |
Medicine and Dentistry | 6 | 24% |
Biochemistry, Genetics and Molecular Biology | 5 | 20% |
Immunology and Microbiology | 1 | 4% |
Computer Science | 1 | 4% |
Other | 0 | 0% |
Unknown | 5 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2014.
All research outputs
#13,411,291
of 22,760,687 outputs
Outputs from Clinical Sarcoma Research
#42
of 104 outputs
Outputs of similar age
#109,615
of 230,541 outputs
Outputs of similar age from Clinical Sarcoma Research
#1
of 6 outputs
Altmetric has tracked 22,760,687 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 104 research outputs from this source. They receive a mean Attention Score of 3.4. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,541 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them